A Double-Blind Randomized Controlled Trial on Effect of Atorvastatin on Clinical Symptoms and Laboratory Markers of Patients with Cholecystitis

Read full text Summarise with VIRAT
Authors: Ashutosh Abhishek, Manish Kumar, Sushant Kumar Sharma
Cited by: 0
References: 27

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: Choosing an appropriate approach to lessen cholecystectomy consequences is crucial for patient welfare. We looked into how atorvastatin affected patients having cholecystectomy in terms of inflammatory markers and clinical complaints. Methods: From January to September of 2025, Sri Krishna Medical College and Hospital in Muzaffarpur, Bihar, conducted this double-blind randomized controlled study. In this trial, 47 patients were given 40 mg of atorvastatin (intervention group) and 47 patients were given a placebo every day for four weeks (placebo group). Then, the frequency of fever, abdominal pain, and nausea before and after cholecystectomy, as well as perioperative data (duration of operation, and intraoperative bleeding) and laboratory data [White Blood Count (WBC), C - reactive protein (CRP), Aspartate Amino Transferase (AST), and Alkaline Phosphatase (ALT)] was collected. The data was analyzed using (SPSS Version 22) based on chi-squared, and independent t-tests at the significance level of (P≤0.05). Results: The duration of hospitalization was not significantly different in both groups (P=0.26), however, the duration of operation was significantly longer in the intervention group (P0.05). The volume of intraoperative bleeding in the placebo group was more than the intervention group (P=0.05). The decrease of WBC, CRP, and the ALT levels after cholecystectomy was not statistically different (P>0.05); however, AST level after cholecystectomy was higher in the intervention group (P=0.05). Conclusion: The use of atorvastatin effectively reduced the volume of intraoperative bleeding. However, this intervention with this dose and duration could not have a significant role in reducing the duration of patients’ hospitalization, duration of operation, and levels of WBC, CRP, ALT, and AST.

Fields of Study & Subjects

Gallbladder and Bile Duct Disorders Surgical site infection prevention Lipoproteins and Cardiovascular Health

Publication details

Journal / source
International Journal of Current Pharmaceutical Review and Research
Volume
18
Issue
01
Publication date
30 January 2026
Language
EN